IMBdx (XKRX:461030) Treasury Stock : ₩0 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is IMBdx Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. IMBdx's treasury stock for the quarter that ended in Mar. 2024 was ₩0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

IMBdx Treasury Stock Historical Data

The historical data trend for IMBdx's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMBdx Treasury Stock Chart

IMBdx Annual Data

Trend

Dec21

Dec22

Dec23

Treasury Stock

IMBdx Quarterly Data
	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24
Treasury Stock	Get a 7-Day Free Trial			-	-	-	-	-

IMBdx Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

IMBdx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IMBdx Inc (XKRX:461030) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

131 Gasandigital 1-ro, 21st Floor BYC Highcity Building A, Geumcheon-gu, Seoul, KOR, 08506

Website

https://www.imbdx.com

IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.

IMBdx Headlines

No Headlines